Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$5,672,419
+$339,228 QoQ
Shares Held
22,335
+2.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#1,530
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NIXON PEABODY TRUST CO holds $47,887,604 across 9 Drug Manufacturers - General names. JNJ ranks #4 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,298 | $19,548,311 | |
| 2 | MRK |
Merck & Co., Inc.
|
77,974 | $10,019,659 | |
| 3 | AZN |
Astrazeneca PLC
|
42,186 | $7,999,309 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
22,335 | $5,672,419 | |
| 5 | ABBV |
AbbVie Inc.
|
8,249 | $2,075,778 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
11,564 | $1,460,995 | |
| 7 | AMGN |
Amgen Inc
|
1,381 | $500,087 | |
| 8 | NVS |
Novartis AG
|
2,136 | $334,753 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,672,419 | 22,335 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $5,333,191 | 21,818 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $5,488,727 | 26,522 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $5,304,495 | 28,608 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $4,580,514 | 29,987 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $6,659,305 | 40,155 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $13,665,288 | 94,491 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $17,370,725 | 107,187 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $15,858,652 | 108,502 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $17,659,698 | 111,636 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $16,723,217 | 106,694 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,225,356 | 14,288 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $886,028 | 5,353 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $212,505 | 1,371 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $289,529 | 1,639 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $264,806 | 1,621 | Shares | Sole | 2023-03-15 | |
| 2022-06-30 | $342,594 | 1,930 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $411,173 | 2,320 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $573,255 | 3,351 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $803,139 | 4,973 | Shares | Other | 2021-11-04 | |
| 2021-06-30 | $367,534 | 2,231 | Shares | Other | 2021-07-30 | |
| 2021-03-31 | $391,316 | 2,381 | Shares | Other | 2021-04-26 | |
| 2020-12-31 | $362,130 | 2,301 | Shares | Other | 2021-02-10 | |
| 2020-09-30 | $380,686 | 2,557 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $359,590 | 2,557 | Shares | Other | 2020-08-13 | |
| 2020-03-31 | $525,044 | 4,004 | Shares | Other | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||